Annual EBIT
-$21.72 M
+$2.98 M+12.06%
December 31, 2023
Summary
- As of February 7, 2025, NERV annual earnings before interest & taxes is -$21.72 million, with the most recent change of +$2.98 million (+12.06%) on December 31, 2023.
- During the last 3 years, NERV annual EBIT has fallen by -$23.66 million (-1219.25%).
- NERV annual EBIT is now -1219.25% below its all-time high of $1.94 million, reached on December 31, 2020.
Performance
NERV EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$22.51 M
+$28.43 M+480.19%
September 30, 2024
Summary
- As of February 7, 2025, NERV quarterly earnings before interest & taxes is $22.51 million, with the most recent change of +$28.43 million (+480.19%) on September 30, 2024.
- Over the past year, NERV quarterly EBIT has increased by +$28.25 million (+492.52%).
- NERV quarterly EBIT is now -23.76% below its all-time high of $29.53 million, reached on June 30, 2020.
Performance
NERV Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$3.44 M
+$28.25 M+113.87%
September 30, 2024
Summary
- As of February 7, 2025, NERV TTM earnings before interest & taxes is $3.44 million, with the most recent change of +$28.25 million (+113.87%) on September 30, 2024.
- Over the past year, NERV TTM EBIT has increased by +$23.13 million (+117.47%).
- NERV TTM EBIT is now -47.74% below its all-time high of $6.58 million, reached on March 31, 2021.
Performance
NERV TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NERV EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.1% | +492.5% | +117.5% |
| 3 y3 years | -1219.3% | +492.5% | +117.5% |
| 5 y5 years | +56.6% | +492.5% | +117.5% |
NERV EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +52.1% | at high | +205.3% | at high | +107.5% |
| 5 y | 5-year | -1219.3% | +71.4% | -23.8% | +169.6% | -47.7% | +104.5% |
| alltime | all time | -1219.3% | +71.4% | -23.8% | +169.6% | -47.7% | +104.5% |
Minerva Neurosciences EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $22.51 M(-480.2%) | $3.44 M(-113.9%) |
| Jun 2024 | - | -$5.92 M(-6.3%) | -$24.81 M(+7.6%) |
| Mar 2024 | - | -$6.32 M(-7.5%) | -$23.05 M(+6.1%) |
| Dec 2023 | -$21.72 M(-12.1%) | -$6.83 M(+19.1%) | -$21.72 M(+10.3%) |
| Sep 2023 | - | -$5.74 M(+37.8%) | -$19.69 M(+3.7%) |
| Jun 2023 | - | -$4.16 M(-16.7%) | -$18.98 M(-12.6%) |
| Mar 2023 | - | -$4.99 M(+4.0%) | -$21.71 M(-12.1%) |
| Dec 2022 | -$24.70 M(-45.6%) | -$4.80 M(-4.5%) | -$24.70 M(-40.2%) |
| Sep 2022 | - | -$5.03 M(-27.1%) | -$41.28 M(-5.7%) |
| Jun 2022 | - | -$6.89 M(-13.7%) | -$43.77 M(-4.5%) |
| Mar 2022 | - | -$7.99 M(-62.6%) | -$45.86 M(+1.1%) |
| Dec 2021 | -$45.38 M(-2438.3%) | -$21.38 M(+184.3%) | -$45.38 M(+44.9%) |
| Sep 2021 | - | -$7.52 M(-16.3%) | -$31.33 M(-1.9%) |
| Jun 2021 | - | -$8.98 M(+19.6%) | -$31.92 M(-584.9%) |
| Mar 2021 | - | -$7.51 M(+2.5%) | $6.58 M(+239.2%) |
| Dec 2020 | $1.94 M(-102.6%) | -$7.32 M(-9.7%) | $1.94 M(-108.4%) |
| Sep 2020 | - | -$8.11 M(-127.5%) | -$23.10 M(-21.1%) |
| Jun 2020 | - | $29.53 M(-343.0%) | -$29.27 M(-59.2%) |
| Mar 2020 | - | -$12.15 M(-62.5%) | -$71.70 M(-5.5%) |
| Dec 2019 | -$75.87 M(+51.5%) | -$32.37 M(+126.6%) | -$75.87 M(+33.8%) |
| Sep 2019 | - | -$14.28 M(+10.7%) | -$56.70 M(+4.2%) |
| Jun 2019 | - | -$12.90 M(-20.9%) | -$54.44 M(+0.8%) |
| Mar 2019 | - | -$16.31 M(+23.5%) | -$54.03 M(+7.9%) |
| Dec 2018 | -$50.06 M | -$13.20 M(+9.9%) | -$50.06 M(+8.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$12.02 M(-3.8%) | -$45.97 M(+2.0%) |
| Jun 2018 | - | -$12.49 M(+1.2%) | -$45.07 M(+6.8%) |
| Mar 2018 | - | -$12.35 M(+35.5%) | -$42.19 M(+4.7%) |
| Dec 2017 | -$40.29 M(+34.2%) | -$9.11 M(-18.1%) | -$40.29 M(-0.2%) |
| Sep 2017 | - | -$11.12 M(+15.7%) | -$40.35 M(+7.9%) |
| Jun 2017 | - | -$9.61 M(-8.0%) | -$37.39 M(+14.3%) |
| Mar 2017 | - | -$10.44 M(+13.9%) | -$32.72 M(+9.0%) |
| Dec 2016 | -$30.02 M(+15.3%) | -$9.17 M(+12.3%) | -$30.02 M(+3.5%) |
| Sep 2016 | - | -$8.16 M(+65.1%) | -$29.01 M(+9.4%) |
| Jun 2016 | - | -$4.95 M(-36.1%) | -$26.51 M(-5.0%) |
| Mar 2016 | - | -$7.73 M(-5.2%) | -$27.90 M(+7.2%) |
| Dec 2015 | -$26.03 M(-52.5%) | -$8.16 M(+44.0%) | -$26.03 M(+2.8%) |
| Sep 2015 | - | -$5.67 M(-10.5%) | -$25.31 M(-45.9%) |
| Jun 2015 | - | -$6.33 M(+8.0%) | -$46.78 M(-19.5%) |
| Mar 2015 | - | -$5.86 M(-21.2%) | -$58.08 M(+5.9%) |
| Dec 2014 | -$54.85 M(+1612.0%) | -$7.44 M(-72.6%) | -$54.85 M(+10.9%) |
| Sep 2014 | - | -$27.14 M(+53.9%) | -$49.48 M(+116.8%) |
| Jun 2014 | - | -$17.64 M(+570.7%) | -$22.82 M(+310.5%) |
| Mar 2014 | - | -$2.63 M(+27.1%) | -$5.56 M(+73.7%) |
| Dec 2013 | -$3.20 M(+102.5%) | -$2.07 M(+326.1%) | -$3.20 M(+182.6%) |
| Sep 2013 | - | -$485.40 K(+29.1%) | -$1.13 M(+75.0%) |
| Jun 2013 | - | -$376.00 K(+38.6%) | -$647.30 K(+138.6%) |
| Mar 2013 | - | -$271.30 K | -$271.30 K |
| Dec 2012 | -$1.58 M | - | - |
FAQ
- What is Minerva Neurosciences annual earnings before interest & taxes?
- What is the all time high annual EBIT for Minerva Neurosciences?
- What is Minerva Neurosciences annual EBIT year-on-year change?
- What is Minerva Neurosciences quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Minerva Neurosciences?
- What is Minerva Neurosciences quarterly EBIT year-on-year change?
- What is Minerva Neurosciences TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Minerva Neurosciences?
- What is Minerva Neurosciences TTM EBIT year-on-year change?
What is Minerva Neurosciences annual earnings before interest & taxes?
The current annual EBIT of NERV is -$21.72 M
What is the all time high annual EBIT for Minerva Neurosciences?
Minerva Neurosciences all-time high annual earnings before interest & taxes is $1.94 M
What is Minerva Neurosciences annual EBIT year-on-year change?
Over the past year, NERV annual earnings before interest & taxes has changed by +$2.98 M (+12.06%)
What is Minerva Neurosciences quarterly earnings before interest & taxes?
The current quarterly EBIT of NERV is $22.51 M
What is the all time high quarterly EBIT for Minerva Neurosciences?
Minerva Neurosciences all-time high quarterly earnings before interest & taxes is $29.53 M
What is Minerva Neurosciences quarterly EBIT year-on-year change?
Over the past year, NERV quarterly earnings before interest & taxes has changed by +$28.25 M (+492.52%)
What is Minerva Neurosciences TTM earnings before interest & taxes?
The current TTM EBIT of NERV is $3.44 M
What is the all time high TTM EBIT for Minerva Neurosciences?
Minerva Neurosciences all-time high TTM earnings before interest & taxes is $6.58 M
What is Minerva Neurosciences TTM EBIT year-on-year change?
Over the past year, NERV TTM earnings before interest & taxes has changed by +$23.13 M (+117.47%)